Daffohils Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-06-2024
- Paid Up Capital ₹ 5.00 M
as on 23-06-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.29 Cr
as on 23-06-2024
- Satisfied Charges ₹ 5.04 Cr
as on 23-06-2024
About Daffohils Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.29 Cr. The company has closed loans amounting to ₹5.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Inderpal Chawla and Sunit Chawla serve as directors at the Company.
- CIN/LLPIN
U24232UR2004PTC028623
- Company No.
028623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Daffohils Laboratories Private Limited offer?
Daffohils Laboratories Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Dry Syrups, Antibiotic Tablets & Capsules, Cefixime Tablet, Pharmaceutical Tablets, Azithromycin Tablets, Multivitamin Tablets & Capsules, Antioxidant Capsule, Bath Soaps, Medicated Soap.
Who are the key members and board of directors at Daffohils Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Inderpal Chawla  | Managing Director | 14-May-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunit Chawla | Director | 05-Mar-2021 | Current |
Financial Performance of Daffohils Laboratories.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Daffohils Laboratories?
Unlock access to Daffohils Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Scottsdale's Hospitality LlpActive 5 years 7 monthsInderpal Chawla and Sunit Chawla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Jan 2022 | ₹3.50 Cr | Open |
Axis Bank Limited Creation Date: 19 Nov 2021 | ₹5.34 M | Open |
Axis Bank Limited Creation Date: 09 Jul 2021 | ₹1.60 M | Open |
How Many Employees Work at Daffohils Laboratories?
Unlock and access historical data on people associated with Daffohils Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daffohils Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffohils Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
